Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now full pipeline small index

Degenerative Spondylolisthesis: full-pipeline trial registry

1 of 6 indexed Degenerative Spondylolisthesis trials are currently recruiting.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 1 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Degenerative Spondylolisthesis: 6 US clinical trials tracked, 1 recruiting.

Degenerative Spondylolisthesis is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Lahey Clinic, running 2 of these trials.

Enrollment posture brief

Registry condition degenerative-spondylolisthesis

OPEN 1 | RECR 17% | LATE 1 | EARLY 1 | RANK #2866 | SPON 2

Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)

Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%Degenerative Spondylolis (th…17%
Open-enrollment share among volume-matched conditions near Degenerative Spondylolisthesis

Degenerative Spondylolisthesis lists 1 open slots (17% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Degenerative Spondylolisthesis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Degenerative Spondylolisthesis is recruiting below its size-band peers.

    1 of 6 indexed trials (16.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Degenerative Spondylolisthesis research.

    Lahey Clinic accounts for 2 of 6 trials (33.3%). 5 distinct sponsors appear on at least one study for this condition label.

  3. Typical Degenerative Spondylolisthesis enrolment sits around 202 participants.

    Median target enrolment is 202 among the 6 trials that report a genuine target (sentinel values excluded). 1 of those (16.7%) plan for fewer than 100 participants.

  4. Degenerative Spondylolisthesis splits between interventional and observational designs.

    4 interventional and 2 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Top Sponsors

Lahey Clinic 2 trials
Empirical Spine 1 trials
John O'Toole 1 trials
Mesoblast 1 trials
Zimmer Biomet 1 trials

Named interventions

Most-linked intervention names on Degenerative Spondylolisthesis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Concorde Bullet Device Device
1 trials
Conduit Titanium Interbody Graft Device
1 trials
SpineLink® , SpineLink® II Device
1 trials
Lumbar Interbody Fusion with NeoFuse Biological
1 trials
Lumbar Interbody Fusion with Autograft Biological
1 trials
Fusion Procedure
1 trials
Fusion Instrumentation Device
1 trials
LimiFlex Device
1 trials

US sites by state

Facility locations filed on Degenerative Spondylolisthesis trials. A trial with sites in several states counts in each.

California 4 trials
Massachusetts 3 trials
Indiana 3 trials
Illinois 3 trials
Florida 3 trials
Kentucky 2 trials
Colorado 2 trials
Arizona 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Degenerative Spondylolisthesis page

6 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Degenerative Spondylolisthesis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Lahey Clinic sponsors the most Degenerative Spondylolisthesis trials on record, review their full trial history before evaluating a specific study. See Lahey Clinic's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Degenerative Spondylolisthesis condition card totals 6 registered trials; most-linked intervention Concorde Bullet Device; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.